149 related articles for article (PubMed ID: 19362505)
1. Thiazolidinediones: antidiabetic agents with effects on bone.
Debiais F
Joint Bone Spine; 2009 May; 76(3):221-3. PubMed ID: 19362505
[No Abstract] [Full Text] [Related]
2. Effect of thiazolidinediones on skeletal health in women with Type 2 diabetes.
Schwartz AV; Sellmeyer DE
Expert Opin Drug Saf; 2008 Jan; 7(1):69-78. PubMed ID: 18171315
[TBL] [Abstract][Full Text] [Related]
3. The peroxisome proliferator-activated receptor-gamma agonist rosiglitazone increases bone resorption in women with type 2 diabetes: a randomized, controlled trial.
Gruntmanis U; Fordan S; Ghayee HK; Abdullah SM; See R; Ayers CR; McGuire DK
Calcif Tissue Int; 2010 May; 86(5):343-9. PubMed ID: 20354684
[TBL] [Abstract][Full Text] [Related]
4. Effects of pioglitazone on bone in postmenopausal women with impaired fasting glucose or impaired glucose tolerance: a randomized, double-blind, placebo-controlled study.
Bone HG; Lindsay R; McClung MR; Perez AT; Raanan MG; Spanheimer RG
J Clin Endocrinol Metab; 2013 Dec; 98(12):4691-701. PubMed ID: 24057294
[TBL] [Abstract][Full Text] [Related]
5. Thiazolidinedione treatment decreases bone mineral density in type 2 diabetic men.
Yaturu S; Bryant B; Jain SK
Diabetes Care; 2007 Jun; 30(6):1574-6. PubMed ID: 17363747
[No Abstract] [Full Text] [Related]
6. Bone loss in diabetes: use of antidiabetic thiazolidinediones and secondary osteoporosis.
Lecka-Czernik B
Curr Osteoporos Rep; 2010 Dec; 8(4):178-84. PubMed ID: 20809203
[TBL] [Abstract][Full Text] [Related]
7. Effects of rosiglitazone on bone mineral density and remodelling parameters in Postmenopausal diabetic women: a 2-year follow-up study.
Berberoglu Z; Yazici AC; Demirag NG
Clin Endocrinol (Oxf); 2010 Sep; 73(3):305-12. PubMed ID: 20148906
[TBL] [Abstract][Full Text] [Related]
8. Long-term use of thiazolidinediones and fractures in type 2 diabetes: a meta-analysis.
Loke YK; Singh S; Furberg CD
CMAJ; 2009 Jan; 180(1):32-9. PubMed ID: 19073651
[TBL] [Abstract][Full Text] [Related]
9. Effects of thiazolidinediones on bone loss and fracture.
Murphy CE; Rodgers PT
Ann Pharmacother; 2007 Dec; 41(12):2014-8. PubMed ID: 17940125
[TBL] [Abstract][Full Text] [Related]
10. Type 2 diabetes, thiazolidinediones: bad to the bone?
Watts NB; D'Alessio DA
J Clin Endocrinol Metab; 2006 Sep; 91(9):3276-8. PubMed ID: 16960122
[No Abstract] [Full Text] [Related]
11. Diabetes drug pioglitazone (Actos): risk of fracture.
Meymeh RH; Wooltorton E
CMAJ; 2007 Sep; 177(7):723-4. PubMed ID: 17823139
[No Abstract] [Full Text] [Related]
12. Thiazolidinediones: do harms outweigh benefits?
Lipscombe LL
CMAJ; 2009 Jan; 180(1):16-7. PubMed ID: 19073650
[No Abstract] [Full Text] [Related]
13. Effect of the antidiabetic agent pioglitazone on bone metabolism in rats.
Kanda J; Izumo N; Kobayashi Y; Onodera K; Shimakura T; Yamamoto N; Takahashi HE; Wakabayashi H
J Pharmacol Sci; 2017 Sep; 135(1):22-28. PubMed ID: 28928054
[TBL] [Abstract][Full Text] [Related]
14. The risk of fractures associated with thiazolidinediones: a self-controlled case-series study.
Douglas IJ; Evans SJ; Pocock S; Smeeth L
PLoS Med; 2009 Sep; 6(9):e1000154. PubMed ID: 19787025
[TBL] [Abstract][Full Text] [Related]
15. The Effects of Pioglitazone on Bone Formation and Resorption Markers in Type 2 Diabetes Mellitus.
Mori H; Okada Y; Tanaka Y
Intern Med; 2017; 56(11):1301-1306. PubMed ID: 28566590
[TBL] [Abstract][Full Text] [Related]
16. [Thiazolidinediones and skeletal health].
Meier C; Bodmer M; Meier CR; Kraenzlin ME
Rev Med Suisse; 2009 Jun; 5(207):1309-10, 1312-3. PubMed ID: 19626930
[TBL] [Abstract][Full Text] [Related]
17. The effect of thiazolidinediones on BMD and osteoporosis.
McDonough AK; Rosenthal RS; Cao X; Saag KG
Nat Clin Pract Endocrinol Metab; 2008 Sep; 4(9):507-13. PubMed ID: 18695700
[TBL] [Abstract][Full Text] [Related]
18. Combination treatment with pioglitazone and fenofibrate attenuates pioglitazone-mediated acceleration of bone loss in ovariectomized rats.
Samadfam R; Awori M; Bénardeau A; Bauss F; Sebokova E; Wright M; Smith SY
J Endocrinol; 2012 Feb; 212(2):179-86. PubMed ID: 22062085
[TBL] [Abstract][Full Text] [Related]
19. Thiazolidinedione use and the risk of fractures.
Toulis KA; Goulis DG; Anastasilakis AD
CMAJ; 2009 Apr; 180(8):841-2; author reply 842-3. PubMed ID: 19364796
[No Abstract] [Full Text] [Related]
20. Anti-inflammatory effect of antidiabetic thiazolidinediones prevents bone resorption rather than cartilage changes in experimental polyarthritis.
Koufany M; Moulin D; Bianchi A; Muresan M; Sebillaud S; Netter P; Weryha G; Jouzeau JY
Arthritis Res Ther; 2008; 10(1):R6. PubMed ID: 18199331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]